A survey of the world’s largest pharmaceutical companies found that only four were prepared to commit to single-digit percentage increases of the prices of their products annually. Source: Drug Industry…

Glatt Air Techniques did not properly clean manufacturing equipment and failed to quarantine drug products before release, according to the FDA. Source: Drug Industry Daily

Jazz Pharmaceuticals settled a seven-year long patent infringement suit over generic copies of its Xyrem solution for narcolepsy, just weeks before the case was scheduled to go to trial. Source:…

Manufacturers and industry groups urged the FDA to develop guidance on its processes for assigning a lead center for the review of a combination product. Source: Drug Industry Daily